<DOC>
	<DOCNO>NCT02767492</DOCNO>
	<brief_summary>This study include patient diagnosed knee OA recommend knee injection . Study subject randomize receive either standard care knee injection ( steroid ) amniotic tissue injection ( BioDRestore ) . Study subject ask permission baseline knee aspiration prior knee injection . At 6 month post-injection , knee aspiration take sent analysis . Study subject follow 1 year post-injection include range motion measurement patient-reported pain/functional outcome measurement . X-rays also take 1-year post-injection appointment .</brief_summary>
	<brief_title>Steroid Injection vs. BioDRestore Patients With Knee OA</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Male female , age 18 80 year . Willing able give voluntary inform consent participate investigation . Patient present knee osteoarthritis Kellgren Lawrence grade 24 ( OA diagnose confirm treat physician use stand xray ) . Candidate intraarticular knee injection . BMI &lt; 40 Patients receive intraarticular injection ( ) last 3 month . Patients undergone arthroscopic surgery study knee past year . Patients undergone arthroplasty study knee . Ligament instability Diabetes ( Type 1 II ) Inflammatory arthropathy . Fibromyalgia chronic fatigue syndrome . Female patient pregnant nursing . Chronic use narcotic . Any reason ( judgment investigator ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>